Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.

• Status: Completed
• Trial end date: 2019-07-31

Summary

This study will examine the renal sparing impact of implementing a strategy of conversion to everolimus from a calcineurin inhibitor based immunosuppressive protocol at 3 months post liver transplant

• Phase: N/A

Details

• Lead Sponsor: Milton S. Hershey Medical Center
• Collaborator: Novartis Pharmaceuticals
• Treatments: Calcineurin Inhibitors; Cyclosporine; Cyclosporins; Everolimus; Mycophenolate mofetil; Mycophenolic Acid; Sirolimus; Tacrolimus